News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
676,839 Results
Type
Article (53234)
Company Profile (355)
Press Release (623250)
Multimedia
Podcasts (93)
Webinars (13)
Section
Business (192519)
Career Advice (2135)
Deals (32794)
Drug Delivery (119)
Drug Development (82185)
Employer Resources (164)
FDA (16157)
Job Trends (14336)
News (328725)
Policy (30407)
Tag
2024 BioCapital Digital (13)
2024 BioForest Digital (9)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (9)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (6)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (12)
2024 Pharm Country Digital (9)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2862)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (89)
Alliances (49476)
ALS (98)
Alzheimer's disease (1479)
Antibody-drug conjugate (ADC) (151)
Approvals (16129)
Artificial intelligence (270)
Autoimmune disease (27)
Automation (14)
Bankruptcy (320)
Best Places to Work (11465)
BIOSECURE Act (22)
Biosimilars (115)
Biotechnology (251)
Bladder cancer (72)
Brain cancer (30)
Breast cancer (289)
Cancer (2312)
Cardiovascular disease (197)
Career advice (1794)
Career pathing (34)
CAR-T (167)
Cell therapy (463)
Cervical cancer (21)
Clinical research (66311)
Collaboration (877)
Compensation (503)
Complete response letters (30)
COVID-19 (2787)
CRISPR (45)
C-suite (249)
Cystic fibrosis (106)
Data (2139)
Decentralized trials (2)
Denatured (31)
Depression (51)
Diabetes (284)
Diagnostics (6357)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (40)
Drug discovery (127)
Drug pricing (112)
Drug shortages (30)
Duchenne muscular dystrophy (100)
Earnings (74421)
Editorial (40)
Employer branding (21)
Employer resources (145)
Events (106199)
Executive appointments (737)
FDA (17404)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (784)
Gene editing (115)
Generative AI (23)
Gene therapy (338)
GLP-1 (816)
Government (4567)
Grass and pollen (6)
Guidances (52)
Healthcare (18946)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (140)
Indications (29)
Infectious disease (2945)
Inflammatory bowel disease (146)
Inflation Reduction Act (10)
Influenza (56)
Intellectual property (95)
Interviews (370)
IPO (15994)
IRA (46)
Job creations (3325)
Job search strategy (1530)
Kidney cancer (11)
Labor market (31)
Layoffs (519)
Leadership (21)
Legal (6374)
Liver cancer (78)
Lung cancer (335)
Lymphoma (152)
Machine learning (6)
Management (60)
Manufacturing (328)
MASH (73)
Medical device (13344)
Medtech (13348)
Mergers & acquisitions (17359)
Metabolic disorders (747)
Multiple sclerosis (82)
NASH (22)
Neurodegenerative disease (106)
Neuropsychiatric disorders (34)
Neuroscience (2052)
NextGen: Class of 2025 (6499)
Non-profit (4506)
Northern California (2612)
Now hiring (32)
Obesity (406)
Opinion (252)
Ovarian cancer (74)
Pain (91)
Pancreatic cancer (84)
Parkinson's disease (156)
Partnered (22)
Patents (237)
Patient recruitment (106)
Peanut (50)
People (57445)
Pharmaceutical (86)
Pharmacy benefit managers (17)
Phase I (20872)
Phase II (29356)
Phase III (21850)
Pipeline (1178)
Policy (150)
Postmarket research (2357)
Preclinical (8926)
Press Release (71)
Prostate cancer (105)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (420)
Real estate (5778)
Recruiting (67)
Regulatory (21658)
Reports (31)
Research institute (2582)
Resumes & cover letters (316)
Rett syndrome (4)
RNA editing (4)
RSV (48)
Schizophrenia (77)
Series A (138)
Series B (87)
Service/supplier (9)
Sickle cell disease (58)
Southern California (2233)
Special edition (18)
Spinal muscular atrophy (162)
Sponsored (30)
Startups (3781)
State (1)
Stomach cancer (16)
Supply chain (74)
Tariffs (33)
The Weekly (60)
United States (22748)
Vaccines (766)
Venture capitalists (43)
Weight loss (288)
Women's health (32)
Worklife (19)
Date
Today (42)
Last 7 days (661)
Last 30 days (2438)
Last 365 days (33680)
2025 (10170)
2024 (36282)
2023 (40995)
2022 (52189)
2021 (56517)
2020 (54373)
2019 (46685)
2018 (35555)
2017 (33301)
2016 (32376)
2015 (37898)
2014 (29574)
2013 (24701)
2012 (26255)
2011 (26873)
2010 (23969)
Location
Africa (813)
Alabama (59)
Alaska (7)
Arizona (166)
Arkansas (13)
Asia (41063)
Australia (7049)
California (5976)
Canada (1958)
China (536)
Colorado (250)
Connecticut (268)
Delaware (137)
Europe (92817)
Florida (879)
Georgia (207)
Idaho (52)
Illinois (520)
India (28)
Indiana (277)
Iowa (9)
Japan (161)
Kansas (104)
Kentucky (24)
Louisiana (11)
Maine (69)
Maryland (915)
Massachusetts (4566)
Michigan (225)
Minnesota (393)
Mississippi (1)
Missouri (85)
Montana (31)
Nebraska (25)
Nevada (58)
New Hampshire (60)
New Jersey (1683)
New Mexico (29)
New York (1711)
North Carolina (1037)
North Dakota (8)
Northern California (2612)
Ohio (209)
Oklahoma (14)
Oregon (34)
Pennsylvania (1309)
Puerto Rico (10)
Rhode Island (30)
South America (1101)
South Carolina (22)
South Dakota (1)
Southern California (2233)
Tennessee (93)
Texas (886)
Utah (179)
Virginia (153)
Washington D.C. (63)
Washington State (560)
West Virginia (3)
Wisconsin (60)
676,839 Results for "als therapy development institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials
The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, the global leader in location intelligence, to develop the ALS Trial Navigator.
June 21, 2024
·
4 min read
Regulatory
FDA Presses Pause on Atara’s Programs, Play on Amylyx’s ALS Assets
The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a third-party provider while releasing Amylyx’s investigational ALS therapy from a previous pause.
January 22, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Voyager Provides Update on SOD1 ALS Gene Therapy Program
February 11, 2025
·
6 min read
Press Releases
XellSmart’s Allogeneic iPSC-derived Cell Therapies for Parkinson’s Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials
April 16, 2025
·
5 min read
Layoffs
Tenaya Slashes a Third of Workforce To Fund Development of Cardio Gene Therapies
The layoffs will take place throughout 2025 and will mostly affect Tenaya’s research and manufacturing operations. The company is continuing to test its hypertrophic cardiomyopathy gene therapy.
April 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
March 17, 2025
·
6 min read
Press Releases
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS
March 24, 2025
·
3 min read
Press Releases
Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery
March 3, 2025
·
5 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
ALS
HEALEY ALS Trial Serves Up More Disappointment as Denali, AbbVie/Calico Fail
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the latest setbacks for the controversial platform trial, the results from which have largely mirrored the dismal success rate in ALS overall.
January 10, 2025
·
5 min read
·
Heather McKenzie
1 of 67,684
Next
